Table 3.
Assessment of peripheral blood inflammation indexes in the two groups of patients.
| Index | metAstasis, n = 123 | Non-metastasis, n = 201 | P |
|---|---|---|---|
| WBC (× 109/L) | 6.72 (5.7, 8.205) | 6.21 (5.07, 7.51) | 0.082 |
| NEUT (× 109/L) | 4.17 (3.175, 5.74) | 3.655 (2.95, 4.81) | 0.011 |
| LYMP (× 109/L) | 1.62 (1.255, 2.13) | 1.835 (1.41, 2.2875) | 0.09 |
| PLT (× 109/L) | 266 (211, 342) | 253.5 (203.25, 326.25) | 0.593 |
| MON (× 109/L) | 0.43 (0.31, 0.68) | 0.37 (0.29, 0.52) | 0.017 |
| PLR | 161.45 (121.665, 235.36) | 139.04 (108.345, 183.04) | 0.221 |
| NLR | 2.56 (1.66, 4) | 1.975 (1.4925, 2.9725) | 0.003 |
| LWR | 3.52 (2.5, 5.28) | 4.945 (3.25, 6.7375) | 0.002 |
| NWR | 0.64 (0.555, 0.74) | 0.60 (0.51, 0.67) | 0.014 |
| SII | 619.62 (464.755, 1216.465) | 512.725 (363.35, 782.62) | 0.007 |
| SIAI | 305.78 (172.635, 599.355) | 202.23 (119.56, 346.8125) | 0.002 |
| dNLR | 0.64 (0.555,0.74) | 0.60 (0.51, 0.67) | 0.049 |
| MLR | 0.28 (0.19, 0.40) | 0.20 (0.15, 0.31) | 0.002 |
| NLPR | 156.40 (124.71, 239.5) | 153.305 (114.6925, 195.63) | 0.157 |
| SIRI | 1.17 (0.62, 2.21) | 0.75 (0.49,1.25) | < 0.001 |
| PNI | 51.75 (46.8, 56) | 55.175 (50.6625, 58.6625) | < 0.001 |
| ALI | 391.17 (235.4, 584.455) | 536.855 (355.1225, 731.4725) | < 0.001 |
| INF-γ (Pg/ml) | 48.2 (36.45, 68.75) | 46.65 (37.625, 64) | 0.99 |
| TNF-α (Pg/ml) | 30.9 (27.9, 35.6) | 31.3 (28.9, 34.9) | 0.386 |
| IL-10 (Pg/ml) | 12.3 (10.15, 16.05) | 11.6 (9.1, 13.9) | 0.003 |
| IL-6 (Pg/ml) | 14 (11.1, 18.6) | 13.25 (10.9, 16.375) | 0.049 |
| IL-4 (Pg/ml) | 26.4 (22.5, 37.25) | 25.9 (21.9, 31) | 0.117 |
| IL-2 (Pg/ml) | 20.6 (17.55, 23.45) | 19.7 (18.1, 21.675) | 0.189 |
The results revealed statistically significant differences between the two groups for NEUT (P = 0.011), MON (P = 0.017), NLR (P = 0.003), LWR (P = 0.002), NWR (P = 0.014), SII (P = 0.007), SIAI (P = 0.002), dNLR (P = 0.049), MLR (P = 0.002), SIRI (P < 0.001), PNI (P < 0.001), ALI (P < 0.001), IL10 (P = 0.003), and IL6 (P = 0.049).
Significant values are in [bold].